Examples of 'alafenamide' in a sentence
Meaning of "alafenamide"
alafenamide (noun) - A drug component that is used in the treatment of certain medical conditions. It is commonly used in English within the field of medicine and pharmacology
Show more definitions
- A particular derivative of 6-aminopurine
How to use "alafenamide" in a sentence
Basic
Advanced
alafenamide
Tenofovir alafenamide is eliminated following metabolism to tenofovir.
Interaction not studied with tenofovir alafenamide.
Effect of tenofovir alafenamide on other medicinal products.
It contains the active substance tenofovir alafenamide.
It is not known whether tenofovir alafenamide is an inhibitor of other.
The active substances are emtricitabine and tenofovir alafenamide.
Tenofovir alafenamide was not mutagenic or clastogenic in conventional genotoxicity assays.
Vemlidy contains the active substance tenofovir alafenamide.
It is not known whether tenofovir alafenamide is excreted in human milk.
Medicinal products that may affect tenofovir alafenamide.
Tenofovir alafenamide fumarate is mainly eliminated following metabolism to tenofovir.
The active substance is tenofovir alafenamide.
Tenofovir alafenamide was not mutagenic or clastogenic in conventional genotoxic assays.
It is not known whether tenofovir alafenamide is secreted in human milk.
Tenofovir alafenamide hemifumarate is preferably administered as part of a pharmaceutical composition or formulation.
See also
In one embodiment of the invention is provided tenofovir alafenamide hemifumarate.
Emtricitabine and tenofovir alafenamide demonstrated synergistic antiviral activity in cell culture.
Descovy contains the active substances emtricitabine and tenofovir alafenamide.
In one embodiment is provided tenofovir alafenamide hemifumarate in a solid form.
Tenofovir alafenamide had a milder effect on the kidney than tenofovir disoproxil.
It is not known whether rilpivirine or tenofovir alafenamide are excreted in human milk.
Tenofovir alafenamide any other antiviral medicines that contain lamivudine or adefovir dipivoxil.
It is not known whether bictegravir or tenofovir alafenamide is excreted in human milk.
Tenofovir alafenamide is a substrate of OATP in vitro.
Animal studies do not indicate harmful effects of tenofovir alafenamide on fertility.
The antiviral activity of tenofovir alafenamide against laboratory and clinical isolates of.
No pharmacokinetic data are available for emtricitabine and tenofovir alafenamide during pregnancy.
The hemifumarate form of tenofovir alafenamide is also referred to herein as tenofovir alafenamide hemifumarate.
This study was conducted using emtricitabine / tenofovir alafenamide.
In one embodiment is provided tenofovir alafenamide hemifumarate for use in medical therapy.
Tenofovir alafenamide for hepatitis B shows improved kidney and bone safety after a year.
The safety of emtricitabine and tenofovir alafenamide has not been established in these patients.
The active substances are emtricitabine, rilpivirine and tenofovir alafenamide.
No antagonism was observed with emtricitabine or tenofovir alafenamide when combined with other antiretroviral agents.
Tenofovir alafenamide This medicine is subject to additional monitoring.
Chemical stability of the hemifumarate form of tenofovir alafenamide was compared with the monofumarate form.
Tenofovir alafenamide is commonly known as TAF.
The active substances are bictegravir, emtricitabine and tenofovir alafenamide.
It is not known whether tenofovir alafenamide is an inhibitor of other UGT enzymes.
Tenofovir alafenamide is primarily hydrolysed to form tenofovir by carboxylesterase 1 in primary hepatocytes.
In another embodiment is provided tenofovir alafenamide hemifumarate for use to treat an HIV infection.
Tenofovir alafenamide hemifumarate may also be presented as a bolus, electuary, or paste.
Emtricitabine+tenofovir alafenamide containing regimens.
The active substances are elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide.
Emtricitabine / tenofovir alafenamide was taken with food in this study.
Co-administration of fluconazole or isavuconazole may increase plasma concentrations of tenofovir alafenamide.
In one embodiment, tenofovir alafenamide hemifumarate can be prepared using selective crystallization.
Co-administration of rifabutin may decrease tenofovir alafenamide plasma concentrations.
In particular, tenofovir alafenamide may be associated with fumarate, such as monofumarate or hemifumarate.
Co-administration of rifampicin may decrease tenofovir alafenamide plasma concentrations.
